MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$24,027K
Investment in marketable
securities (note 6)
$4,981K
Prepaid and other
current assets
$1,002K
Property and equipment,
net (note 7)
$90K
Non-current prepaid
expenses and other assets
$60K
Total current assets
$30,010K
Total non-current
assets
$150K
Total assets
$30,160K
Total liabilities and
shareholders equity
$30,160K
Total shareholders'
equity
$27,765K
Total liabilities
$2,395K
Accumulated deficit
-$757,653K
Additional paid-in capital
$785,413K
Total current
liabilities
$2,395K
Common stock 0.0001 par
value 150,000,000...
$3K
Accumulated other
comprehensive income
$2K
Trade payables
$1,041K
Accrued expenses (note
8)
$941K
Employee-related obligations
$413K
Back
Back
Balance Sheet
source: myfinsight.com
VYNE Therapeutics Inc. (VYNE)
VYNE Therapeutics Inc. (VYNE)